Clinical Trial Update: Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption [NA]

View source ↗

Summary

This completed study evaluated the safety and feasibility of ExAblate–mediated blood-brain barrier disruption in glioma and glioblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Glioma

Drugs mentioned

• Exablate

Snippet

Sponsor: InSightec | Conditions: Glioma, Glioblastoma | NA | Status: COMPLETED